ArticleAmerican journal of translational research2025
Elevated levels of NT-proBNP, interferon-γ and tumor necrosis factor-α are associated with coronary artery injury in children with severe Kawasaki disease.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of N-terminal probrain natriuretic peptide in predicting Kawasaki disease shock syndrome: a prospective cohort study.European journal of pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the association between N-terminal pro-brain natriuretic peptide (NT-proBNP), interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and coronary artery injury in children with Kawasaki disease (KD).
methodsThis retrospective study included 42 children with KD admitted to Baoding Hospital of Beijing Children's Hospital Capital Medical University from January 2019 to January 2022 (KD group), and 80 healthy children during the same period (control group). Peripheral blood markers including white blood cell count (WBC), red blood cell count (RBC), hemoglobin (Hb), hematocrit (HCT), mean platelet volume (MPV), platelet distribution width (PDW), platelet count (PLT), NT-proBNP, IFN-γ, TNF-α, C-reactive protein (CRP), and circulating endothelial cell count (CEC) were compared between groups. KD patients were further stratified based on the severity of coronary artery involvement for subgroup analysis.
resultsCompared with the control group, the KD group showed significantly higher levels of WBC, PDW, PLT, NT-proBNP, IFN-γ, TNF-α, CRP, and CEC, and significantly lower levels of RBC, Hb, and HCT (all P < 0.05). MPV levels did not differ significantly between groups (P > 0.05). Among the 42 KD patients, 17 had coronary artery involvement. These patients exhibited significantly higher levels of PDW, NT-proBNP, IFN-γ, TNF-α, CRP, and CEC compared to those without coronary artery injury (all P < 0.05). There were no significant differences in WBC, RBC, Hb, HCT, MPV, or PLT between the KD subgroups with and without coronary artery lesions (all P > 0.05). The diagnostic sensitivity of NT-proBNP, IFN-γ, and TNF-α for coronary artery injury in KD was 96.18%, 83.47%, and 65.20%, respectively, with specificities of 78.71%, 82.16%, and 81.98%, respectively. The area under the ROC curve for NT-proBNP, IFN-γ, and TNF-α was 0.969, 0.875, and 0.704, respectively. Logistic regression analysis identified elevated IFN-γ, TNF-α, CRP, and CEC as independent risk factors for coronary artery injury in children with KD (all P < 0.05).
conclusionsNT-proBNP, IFN-γ, and TNF-α levels are significantly elevated in children with severe KD and are closely associated with coronary artery injury. These biomarkers may serve as early predictors of coronary artery complications in KD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.